Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $90.6100 (-1.24%) ($89.4300 - $91.7120) on Thu. Mar. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.74% (three month average) | RSI | 39 | Latest Price | $90.6100(-1.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 1.2% a day on average for past five trading days. | Weekly Trend | ABBV declines -2.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(64%) SPLV(54%) DIA(53%) VYM(53%) IVE(52%) | Factors Impacting ABBV price | ABBV will decline at least -0.87% in a week (0% probabilities). VIXM(-37%) VXX(-14%) TLT(-14%) UUP(-1%) IGOV(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.87% (StdDev 1.74%) | Hourly BBV | 0.5 () | Intraday Trend | 0.8% | | | |
|
Inflection Point | Yes | Resistance Level | $91.61 | 5 Day Moving Average | $88.81(2.03%) | 10 Day Moving Average | $89.45(1.3%) | 20 Day Moving Average | $91.61(-1.09%) | To recent high | -7.3% | To recent low | 11.8% | Market Cap | $159.862b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |